Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WSK-V101C Booster in Healthy Adults
NCT05911048Phase 2Not yet recruiting
- Sponsor
- WestVac Biopharma
- Start
- Dec 2024
- Primary completion
- Jun 2025
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of Recombinant COVID-19 bivalent xbb+prototype protein vaccine in coronavirus disease 2019 (COVID-19), sponsored by WestVac Biopharma. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
Recombinant COVID-19 bivalent xbb+prototype protein vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05911048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05911048.